Regencell Bioscience Holdings Limited
RGC
株式のランク
#3437
Regencell Bioscience Holdings Limited is a biotechnology firm specializing in... Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Established in 2014, Regencell Bioscience maintains its primary office in Causeway Bay, Hong Kong.
株価
$10.10
最終同期: 2026-10-19
時価総額
$5.01B
変化（1日）
5.32%
変化（1年）
-40.45%
国
HK
取引 Regencell Bioscience Holdings Limited (RGC)
カテゴリー
Healthcare
Regencell Bioscience Holdings Limited（RGC）の配当履歴
Regencell Bioscience Holdings Limited（証券コード：RGC）は合計で36回の配当を行いました。
すべての配当の合計（株式分割調整済み）は：$7.52
配当利回り（TTM）：0
すべての配当の合計（株式分割調整済み）は：$7.52
配当利回り（TTM）：0
2009から2026までのRegencell Bioscience Holdings Limited（RGC）の配当履歴
年間配当支払い
| 年 | 配当（株式分割調整済み） | 変化 |
|---|---|---|
| 2026 (TTM) | $0.22 | 0.00% |
| 2018 | $0.22 | -75.00% |
| 2017 | $0.88 | 0.00% |
| 2016 | $0.88 | 0.00% |
| 2015 | $0.88 | 0.00% |
| 2014 | $0.88 | 4.76% |
| 2013 | $0.84 | 0.00% |
| 2012 | $0.84 | 0.00% |
| 2011 | $0.84 | 16.67% |
| 2010 | $0.72 | 33.33% |
| 2009 | $0.54 | 0.00% |
すべての配当支払いの一覧
| 年 | 配当 | 変化 |
|---|---|---|
| 2026 (TTM) | $8.36 | 0.00% |
| 2018 | $8.36 | -75.00% |
| 2017 | $33.44 | 0.00% |
| 2016 | $33.44 | 0.00% |
| 2015 | $33.44 | 0.00% |
| 2014 | $33.44 | 4.76% |
| 2013 | $31.92 | 0.00% |
| 2012 | $31.92 | 0.00% |
| 2011 | $31.92 | 16.67% |
| 2010 | $27.36 | 33.33% |
| 2009 | $20.52 | 0.00% |
同業他社や競合企業の配当履歴
| 企業 | 配当支払い回数 | 国 |
|---|---|---|
| 0.00% |
DE
|
|
| 0.00% |
DE
|
|
| 0.00% |
JP
|
|
| 0.00% |
CH
|
|
| 38.00% |
IN
|
